TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07269041: Immune Tolerance Induction After Liver Transplantation

Sponsor: University of California, Los Angeles · Phase: PHASE1/PHASE2 · Area: IMMUNOLOGY · Target Enrollment: 20 pts

Competing Trials Overlap

3 Active Trials

Excess Burn Exposure

$8,768,175

Rescue Site Savings

+$5,777,025

Unlock Full NCT07269041 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07269041 Rescue Dossier →